Chris Kyriakidis

Chris Kyriakidis is an accomplished executive with extensive experience in marketing, brand management, and strategic development across various industries, including MedTech and consumer goods. Currently serving as the CEO and Co-Founder of gMendel®, a company specializing in AI-driven diagnostic services for genetic disorders, Chris is also a Board Member at Quaternity, focusing on sustainable technologies and behavioral changes. Previous roles include Co-founder and Strategic Advisor at Besesaka, where impactful changes in children's lives in Ghana were pursued through education and boxing, and Brand Strategist at Right to Dream, which aims to redefine excellence in educational institutions. Chris's career includes significant roles at GN Hearing A/S, ALK, and Novo Nordisk, where strategies and initiatives led to substantial growth and market positioning improvements. Educational credentials include an MBA from Erasmus University and a Ph.D. in Chemistry from the University of Amsterdam.